Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder.

Ross J Baldessarini, Wai Keat Lau, Jordan Sim, Min Yi Sum, Kang Sim

Abstract readLetterReview

In one paragraph

Review in The international journal of neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

Prediction of treatment response in major depressive disorder using a hybrid of convolutional recurrent deep neural networks and effective connectivity based on EEG signal.Physical and engineering sciences in medicine · 2024
Article
Suicidal Risks in Report of Reports of Long-Term Treatment Trials for Major Depressive Disorder.The international journal of neuropsychopharmacology · 2017
Article
Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II.The international journal of neuropsychopharmacology · 2017
Article
Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment.Current psychiatry reports · 2016
Review

4 · The record

Corrections and comments

Commented on by
Suicidal Risks in Report of Reports of Long-Term Treatment Trials for Major Depressive Disorder.2017
Commented on by
Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II.2017

5 · Who and what money

Authors and funding

5 authors.

Ross J BaldessariniDepartment of Psychiatry, Harvard Medical School, Boston, MA (Dr Baldessarini); International Consortium for Psychotic and Mood Disorders Research, McLean Hospital, Belmont, MA (Drs Baldessarini and K Sim); Yong Loo Lin School of Medicine, National University of Singapore (Drs Lau, J Sim, and K Sim); Research Department (Dr K Sim and Ms Sum), and Department of General Psychiatry (Dr K Sim), Institute of Mental Health, Singapore. rbaldessarini@mclean.harvard.edu.

Wai Keat LauDepartment of Psychiatry, Harvard Medical School, Boston, MA (Dr Baldessarini); International Consortium for Psychotic and Mood Disorders Research, McLean Hospital, Belmont, MA (Drs Baldessarini and K Sim); Yong Loo Lin School of Medicine, National University of Singapore (Drs Lau, J Sim, and K Sim); Research Department (Dr K Sim and Ms Sum), and Department of General Psychiatry (Dr K Sim), Institute of Mental Health, Singapore.

Jordan SimDepartment of Psychiatry, Harvard Medical School, Boston, MA (Dr Baldessarini); International Consortium for Psychotic and Mood Disorders Research, McLean Hospital, Belmont, MA (Drs Baldessarini and K Sim); Yong Loo Lin School of Medicine, National University of Singapore (Drs Lau, J Sim, and K Sim); Research Department (Dr K Sim and Ms Sum), and Department of General Psychiatry (Dr K Sim), Institute of Mental Health, Singapore.

Min Yi SumDepartment of Psychiatry, Harvard Medical School, Boston, MA (Dr Baldessarini); International Consortium for Psychotic and Mood Disorders Research, McLean Hospital, Belmont, MA (Drs Baldessarini and K Sim); Yong Loo Lin School of Medicine, National University of Singapore (Drs Lau, J Sim, and K Sim); Research Department (Dr K Sim and Ms Sum), and Department of General Psychiatry (Dr K Sim), Institute of Mental Health, Singapore.

Kang SimDepartment of Psychiatry, Harvard Medical School, Boston, MA (Dr Baldessarini); International Consortium for Psychotic and Mood Disorders Research, McLean Hospital, Belmont, MA (Drs Baldessarini and K Sim); Yong Loo Lin School of Medicine, National University of Singapore (Drs Lau, J Sim, and K Sim); Research Department (Dr K Sim and Ms Sum), and Department of General Psychiatry (Dr K Sim), Institute of Mental Health, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Controlled Clinical Trials as TopicSuicideHumansMajor Depressive DisorderRisk

Identifiers

PMID26371184

DOI10.1093/ijnp/pyv107

PMCPMC4815473

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.